<
>
Orforglipron (2212020-52-3)
Product Summary
Orforglipron (2212020-52-3) is an oral GLP-1 receptor agonist for type 2 diabetes and obesity research. Available for R&D use under patent.
Product Custom Attributes
CAS:
2212020-52-3
MF:
C48H48F2N10O5
Mol. Wt.:
882.96
Storage:
Minus 20°C
Product Description
Orforglipron is a partial agonist of the glucagon-like peptide (GLP-1) receptor with oral activity, and can be used in the research related to type 2 diabetes and obesity.
*The product under patent is only for R&D use.
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.
